Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
covid-19:treatments:drug_therapies:remdesivir [2022/02/16 14:27] pamela | covid-19:treatments:drug_therapies:remdesivir [2022/02/16 16:17] (current) leonardo [Wuhan Gang] | ||
---|---|---|---|
Line 66: | Line 66: | ||
The ball for the newest add-on payments got rolling with the advent of coronavirus therapies. As the regulation explains, the FDA created a program for possible coronavirus therapies called the Coronavirus Treatment Acceleration Program, which includes issuing emergency use authorizations (EUAs) during the PHE. The FDA has issued EUAs for five drugs and biologicals for COVID-19, although only remdesivir and COVID-19 convalescent plasma are eligible for the add-on payment in connection with the inpatient prospective payment system (IPPS). ((https:// | The ball for the newest add-on payments got rolling with the advent of coronavirus therapies. As the regulation explains, the FDA created a program for possible coronavirus therapies called the Coronavirus Treatment Acceleration Program, which includes issuing emergency use authorizations (EUAs) during the PHE. The FDA has issued EUAs for five drugs and biologicals for COVID-19, although only remdesivir and COVID-19 convalescent plasma are eligible for the add-on payment in connection with the inpatient prospective payment system (IPPS). ((https:// | ||
- | ==== FDA Early Treatment Approval 2022 Remdisivir | + | ==== FDA Early Treatment Approval 2022 Remdisivir |
Today, the U.S. Food and Drug Administration took two actions to expand the use of the **antiviral drug Veklury (remdesivir)** to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. This provides another treatment option to reduce the risk of hospitalization in high-risk patients. Previously, the use of Veklury was limited to patients requiring hospitalization. | Today, the U.S. Food and Drug Administration took two actions to expand the use of the **antiviral drug Veklury (remdesivir)** to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. This provides another treatment option to reduce the risk of hospitalization in high-risk patients. Previously, the use of Veklury was limited to patients requiring hospitalization. | ||
- | “On the heels of the FDA’s recent authorization of two oral antiviral drugs, today’s actions bolster the arsenal of therapeutics to treat COVID-19 and respond to the surge of the omicron variant,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Today’s actions provide adults and pediatric patients, with mild-to-moderate COVID-19 who are at high risk of severe COVID-19, with a treatment option they could receive outside of a traditional inpatient hospital setting, including at skilled nursing facilities, home healthcare settings and outpatient facilities such as infusion centers.” ((https:// | + | “On the heels of the FDA’s recent authorization of two oral antiviral drugs, today’s actions bolster the arsenal of therapeutics to treat COVID-19 and respond to the surge of the omicron variant,” said [[Patrizia Cavazzoni]], M.D., director of the FDA’s Center for Drug Evaluation and Research. “Today’s actions provide adults and pediatric patients, with mild-to-moderate COVID-19 who are at high risk of severe COVID-19, with a treatment option they could receive outside of a traditional inpatient hospital setting, including at skilled nursing facilities, home healthcare settings and outpatient facilities such as infusion centers.” ((https:// |
+ | see also FORBES - The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work((https:// | ||
+ | ==== Wuhan Gang ==== | ||
+ | Donald Trump was treated with remdesivir in the way that reason dictates: as soon as possible. [[:Peter Hotez]] commented, matter-of-factly- | ||
+ | |||
+ | Thread on POTUS therapies; Being asked about mab cocktail from Regeneron and remdesivir and what it means? | ||
+ | |||
+ | 'I think a key point is that use of antiviral drugs, if they are to be effective likely must be administered early in the course of the illness during viral replication.' | ||
+ | |||
+ | |||
+ | And yet almost everyone else got the drug when it was already too late for it to help. | ||
+ | |||
+ | Dr. [[:Anthony Fauci]] speaks on the clinical trial for potential coronavirus treatment drug remdesivir; | ||
+ | |||
+ | “What it has proven is that a drug can block this virus ... This drug happens to be blocking an enzyme that the virus uses." ((https:// | ||
+ | |||
+ | As a side note, besides Fauci, a cast of characters well known among those who have been investigating the lab leak hypothesis make their appearance. [[:Peter Daszak]] was sure to claim credit for assisting in the development of remdesivir. (60 minutes) ((https:// | ||
+ | "The breakthrough drug Remdesivir that seems to have some impact on COVID-19, was actually tested against the viruses we discovered under our NIH research," | ||
+ | |||
+ | But the real hero in the development of remdesivir is Mr. Gain-of-function himself, [[:Ralph Baric]]. What was his role? Allow him to explain.. | ||
+ | |||
+ | " | ||
+ | |||
+ | "It offers real hope to humans infected with this terrible virus." | ||
+ | |||
+ | ((https:// | ||